摘要
目的:了解全国范围内医疗机构中药饮片再加工开展现状。方法:以全国各地区医疗机构为调查对象,借助“问卷星”平台发放自拟电子问卷调查表,内容包括医疗机构基本情况、中药饮片再加工项目开展现状、人员配置、设施设备情况、质量控制体系和疗效反馈评价等。结果:共264家医疗机构参与调研,覆盖30个省、自治区、直辖市、特别行政区,以中医医院(116家,占43.9%)和三级医院(203家,占76.9%)为主;152家医疗机构(占57.6%)有中药饮片再加工的需求,但仅有20家医疗机构(占7.6%)全面开展了中药饮片再加工项目。已开展中药饮片再加工项目的101家医疗机构中,39家医疗机构(占38.6%)有专职药师负责;89家医疗机构(占88.1%)从事中药饮片再加工项目的药师占比≤20%;22家医疗机构(占21.8%)设有独立的炮制和加工室;75家医疗机构(占74.3%)建立有中药饮片再加工管理制度;89家医疗机构(占88.1%)具有工作记录留存机制;仅49家医疗机构(占48.5%)实现临床疗效评价反馈追溯。临方炮制以粉碎、炒制和切制为主,临方制剂以煎膏剂、散剂、丸剂为主要剂型。结论:中药饮片再加工涵盖中药临方炮制及“一人一方”临方制剂加工,合理解决当下不足,对推动中医临床辨证施治与中医药特色的充分发挥具有重要意义。
OBJECTIVE:To investigate the reprocessing status of traditional Chinese medicine decoction pieces in medical institutions in China.METHODS:Medical institutions from various regions in China were surveyed by using a self-designed electronic questionnaire distributed via the“Qestionnaire Star”platform.The questionnaire covered basic information about the medical institutions,status of traditional Chinese medicine decoction piece reprocessing projects,staffing,equipment and facilities,quality control system,and feedback on therapeutic efficacy.RESULTS:A total of 264 medical institutions from 30 provinces,autonomous regions,municipalities,and special administrative regions participated into the survey,with traditional Chinese medicine hospitals(116 cases,43.9%)and tertiary hospitals(203 cases,76.9%)being the main participants.There were 152 medical institutions(57.6%)reported a need for reprocessing of traditional Chinese medicine decoction pieces,but only 20 medical institutions(7.6%)had fully implemented such projects.Among the 101 medical institutions that had implemented reprocessing projects of traditional Chinese medicine decoction pieces,39 medical institutions(38.6%)had dedicated pharmacists responsible for the task;89 medical institutions(88.1%)had less than or equal to 20%of the pharmacists engaged in such projects;22 medical institutions(21.8%)had independent sites for on-demand herbal processing and preparation;75 medical institutions(74.3%)had established a reprocessing management system for prepared herbal slices;89 medical institutions(88.1%)had mechanisms for work records retention;established relatively comprehensive quality control systems for reprocessing projects of traditional Chinese medicine decoction pieces;only 49 medical institutions(48.5%)had implemented clinical efficacy evaluation and feedback tracing.Prescription-based processing of Chinese herbal pieces mainly involved pulverization,stir-frying and cutting,while the main formulations for clinical prescription processing were soft extract,powders and pilula.CONCLUSIONS:The reprocessing of traditional Chinese medicine decoction pieces covers prescription-based processing of Chinese herbal pieces and the processing of“one person and one prescription”clinical preparation.It is of great significance to promote the clinical differentiation and treatment of traditional Chinese medicine and give full play to the characteristics of traditional Chinese medicine to solve the current shortcomings rationally.
作者
李茜
路瑶
王鑫鑫
丁晓晓
张丽娜
郭丹丹
郭桂明
LI Qian;LU Yao;WANG Xinxin;DING Xiaoxiao;ZHANG Lina;GUO Dandan;GUO Guiming(Dept.of Pharmacy,Beijing Royal Integrative Medicine Hospital,Beijing 102200,China;Dept.of Pharmacy,Liaoning Fangda General Hospital,Shenyang 110172,China;Pharmaceutical Quality Control Center,Beijing Administration of Traditional Chinese Medicine,Beijing 100027,China)
出处
《中国医院用药评价与分析》
2025年第8期932-937,共6页
Evaluation and Analysis of Drug-use in Hospitals of China
基金
国家中医药管理局监测统计中心深化医改中医药政策研究自选课题(No.YGZXKT2024033)
2023年全国中药特色技术传承人才培训项目(No.国中医药人教函〔2023〕20号)
第六批北京市级中医药专家学术经验继承工作资助项目(No.京中医科字〔2022〕79号)。
关键词
中药饮片再加工
医疗机构
调研
临方炮制
临方制剂
质量控制
Reprocessing of traditional Chinese medicine decoction pieces
Medical institutions
Investigations
Prescription-based processing of Chinese herbal pieces
Clinical prescription processing
Quality control
